Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Measurement of phospholipid metabolism in intact neutrophils.

Sergeant S, McPhail LC.

Methods Mol Biol. 2014;1124:89-105. doi: 10.1007/978-1-62703-845-4_7.

PMID:
24504948
2.

Angeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin.

Solomon SB, Bellavia L, Sweeney D, Piknova B, Perlegas A, Helms CC, Ferreyra GA, Bruce King S, Raat NJ, Kern SJ, Sun J, McPhail LC, Schechter AN, Natanson C, Gladwin MT, Kim-Shapiro DB.

Free Radic Biol Med. 2012 Dec 15;53(12):2229-39. doi: 10.1016/j.freeradbiomed.2012.10.548. Epub 2012 Oct 23.

3.

The NOXO1β PX domain preferentially targets PtdIns(4,5)P2 and PtdIns(3,4,5)P3.

Davis NY, McPhail LC, Horita DA.

J Mol Biol. 2012 Apr 13;417(5):440-53. doi: 10.1016/j.jmb.2012.01.058. Epub 2012 Feb 8.

4.

Backbone 1H, 15N, and 13C resonance assignments for the NOXO1β PX domain.

Davis NY, McPhail LC, Horita DA.

Biomol NMR Assign. 2011 Oct;5(2):139-41. doi: 10.1007/s12104-010-9286-x. Epub 2010 Dec 28.

5.

Phosphorylation of p22phox on threonine 147 enhances NADPH oxidase activity by promoting p47phox binding.

Lewis EM, Sergeant S, Ledford B, Stull N, Dinauer MC, McPhail LC.

J Biol Chem. 2010 Jan 29;285(5):2959-67. doi: 10.1074/jbc.M109.030643. Epub 2009 Nov 30.

6.

X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation.

Lewis EM, Singla M, Sergeant S, Koty PP, McPhail LC.

Clin Immunol. 2008 Nov;129(2):372-80. doi: 10.1016/j.clim.2008.07.022. Epub 2008 Sep 6.

7.

Mutations in the PX-SH3A linker of p47phox decouple PI(3,4)P2 binding from NADPH oxidase activation.

Shen K, Sergeant S, Hantgan RR, McPhail LC, Horita DA.

Biochemistry. 2008 Aug 26;47(34):8855-65. doi: 10.1021/bi8005847. Epub 2008 Aug 2.

8.

Measurement of phospholipid metabolism in intact neutrophils.

Sergeant S, McPhail LC.

Methods Mol Biol. 2007;412:69-83. doi: 10.1007/978-1-59745-467-4_6.

PMID:
18453106
9.

Membrane targeting by APPL1 and APPL2: dynamic scaffolds that oligomerize and bind phosphoinositides.

Chial HJ, Wu R, Ustach CV, McPhail LC, Mobley WC, Chen YQ.

Traffic. 2008 Feb;9(2):215-29. Epub 2007 Dec 18. Erratum in: Traffic. 2008 Apr;9(4):623-4.

10.

Characterization of surface structure and p47phox SH3 domain-mediated conformational changes for human neutrophil flavocytochrome b.

Taylor RM, Lord CI, Riesselman MH, Gripentrog JM, Leto TL, McPhail LC, Berdichevsky Y, Pick E, Jesaitis AJ.

Biochemistry. 2007 Dec 11;46(49):14291-304. Epub 2007 Nov 16.

PMID:
18004884
11.

Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR.

Lehman N, Ledford B, Di Fulvio M, Frondorf K, McPhail LC, Gomez-Cambronero J.

FASEB J. 2007 Apr;21(4):1075-87. Epub 2007 Jan 22.

PMID:
17242159
12.

Anionic amphiphile and phospholipid-induced conformational changes in human neutrophil flavocytochrome b observed by fluorescence resonance energy transfer.

Taylor RM, Foubert TR, Burritt JB, Baniulis D, McPhail LC, Jesaitis AJ.

Biochim Biophys Acta. 2004 May 27;1663(1-2):201-13.

13.
14.

Phosphatidic acid regulates tyrosine phosphorylating activity in human neutrophils: enhancement of Fgr activity.

Sergeant S, Waite KA, Heravi J, McPhail LC.

J Biol Chem. 2001 Feb 16;276(7):4737-46. Epub 2000 Nov 14.

15.

Phosphatidic acid and diacylglycerol directly activate NADPH oxidase by interacting with enzyme components.

Palicz A, Foubert TR, Jesaitis AJ, Marodi L, McPhail LC.

J Biol Chem. 2001 Feb 2;276(5):3090-7. Epub 2000 Nov 1.

16.
18.
20.

A novel protein kinase target for the lipid second messenger phosphatidic acid.

McPhail LC, Waite KA, Regier DS, Nixon JB, Qualliotine-Mann D, Zhang WX, Wallin R, Sergeant S.

Biochim Biophys Acta. 1999 Jul 30;1439(2):277-90. Review.

PMID:
10425401
21.

Opsonized zymosan stimulates the redistribution of protein kinase C isoforms in human neutrophils.

Sergeant S, McPhail LC.

J Immunol. 1997 Sep 15;159(6):2877-85.

PMID:
9300711
22.
23.

Identification and regulation of protein kinase C-delta in human neutrophils.

Kent JD, Sergeant S, Burns DJ, McPhail LC.

J Immunol. 1996 Nov 15;157(10):4641-7.

PMID:
8906844
24.

Cell-free activation of neutrophil NADPH oxidase by a phosphatidic acid-regulated protein kinase.

McPhail LC, Qualliotine-Mann D, Waite KA.

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7931-5.

25.

SH3-dependent assembly of the phagocyte NADPH oxidase.

McPhail LC.

J Exp Med. 1994 Dec 1;180(6):2011-5. Review. No abstract available.

26.

Activation of phospholipase D by interleukin-8 in human neutrophils.

Sozzani S, Agwu DE, Ellenburg MD, Locati M, Rieppi M, Rojas A, Mantovani A, McPhail LC.

Blood. 1994 Dec 1;84(11):3895-901.

PMID:
7949145
27.

Phosphatidic acid and diacylglycerol synergize in a cell-free system for activation of NADPH oxidase from human neutrophils.

Qualliotine-Mann D, Agwu DE, Ellenburg MD, McCall CE, McPhail LC.

J Biol Chem. 1993 Nov 15;268(32):23843-9.

28.

Phospholipases and activation of the NADPH oxidase.

McPhail LC, Qualliotine-Mann D, Agwu DE, McCall CE.

Eur J Haematol. 1993 Nov;51(5):294-300. Review.

PMID:
8282091
29.

Propranolol, a phosphatidate phosphohydrolase inhibitor, also inhibits protein kinase C.

Sozzani S, Agwu DE, McCall CE, O'Flaherty JT, Schmitt JD, Kent JD, McPhail LC.

J Biol Chem. 1992 Oct 5;267(28):20481-8.

31.

The neutrophil respiratory burst mechanism.

McPhail LC, Strum SL, Leone PA, Sozzani S.

Immunol Ser. 1992;57:47-76. Review. No abstract available.

PMID:
1504145
32.

Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase.

Agwu DE, McPhail LC, Sozzani S, Bass DA, McCall CE.

J Clin Invest. 1991 Aug;88(2):531-9.

33.
34.
35.

Choline-linked phosphoglycerides. A source of phosphatidic acid and diglycerides in stimulated neutrophils.

Agwu DE, McPhail LC, Chabot MC, Daniel LW, Wykle RL, McCall CE.

J Biol Chem. 1989 Jan 25;264(3):1405-13.

36.
37.
38.

Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.

Harvath L, McCall CE, Bass DA, McPhail LC.

J Immunol. 1987 Nov 1;139(9):3055-61.

PMID:
2822802
39.

Priming of the respiratory burst of neutrophils by diacylglycerol. Independence from activation or translocation of protein kinase C.

Bass DA, Gerard C, Olbrantz P, Wilson J, McCall CE, McPhail LC.

J Biol Chem. 1987 May 15;262(14):6643-9.

41.

Stimulus-dependent mobilization of protein kinase C.

Nishihira J, McPhail LC, O'Flaherty JT.

Biochem Biophys Res Commun. 1986 Jan 29;134(2):587-94.

PMID:
3004455
42.
43.
44.
46.
47.

Diacylglycerol activates protein kinase C and modulates oxidative metabolism in human neutrophils.

McCall CE, McPhail LC, Salzer WL, Schmitt JD, Nasrallah V, Kim J, Wykle RL, O'Flaherty JT, Bass DA.

Trans Assoc Am Physicians. 1985;98:253-68. No abstract available.

PMID:
3022443
49.

A potential second messenger role for unsaturated fatty acids: activation of Ca2+-dependent protein kinase.

McPhail LC, Clayton CC, Snyderman R.

Science. 1984 May 11;224(4649):622-5.

PMID:
6231726
50.

The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals.

McPhail LC, Clayton CC, Snyderman R.

J Biol Chem. 1984 May 10;259(9):5768-75.

Supplemental Content

Loading ...
Support Center